510(k) Report

510(k) · Cleared

Recalled · Class II · 2018

Sequencer

K981313510(k) TraditionalCleared Jul 9, 199890-day reviewClass II21 CFR 892.5050Recalls 11

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Impac Medical Systems, Inc. · IYE Accelerator, Linear, Medical

Cleared on Jul 9, 1998 after a 90-day review. The FDA summary names no predicate by number. 9 later devices descend from it. It has been recalled 11 times.

Decided
Jul 9, 1998
Review
90 days
Class
Class II
Product code
IYE
Recalls
11
Predicates
0

9 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2012: 2 descendants cleared2014: 1 descendant cleared2021: 1 descendant cleared2016: 1 descendant cleared2022: 1 descendant cleared2023: 1 descendant cleared2026: 1 descendant cleared2025: 1 descendant cleared1995200020052010201520202025
  1. This deviceK981313 SequencerImpac Medical Systems, Inc. · 1998
  2. Descendant · cites it directly · 8 of its ownK120067 Mosaiq Oncology Information SystemImpac Medical Systems, Inc. · 2012 · Recalled
  3. Descendant · 2 generations on · 5 of its ownK142142 Quality ReportsSun Nuclear Corporation · 2014
  4. Descendant · 3 generations on · 4 of its ownK162468 ClearCheckRadformation · 2016
  5. Descendant · 4 generations on · 3 of its ownK220583 ClearCheck Model RADCC V2Radformation, Inc. · 2022
  6. Descendant · 5 generations on · 1 of its ownK231185 MapRTVision Rt, Ltd. · 2023

Showing 5 of 9 descendants. See all descendants

Descendants cleared per year

2012: 22014: 12016: 12021: 12022: 12023: 12025: 12026: 1
2012high 2 (2012) · low 0 (2013)2026

Most influential descendants

Showing 5 of 9 · See all
  • K120067Mosaiq Oncology Information SystemImpac Medical Systems, Inc. · 2012 · cites it directly8descendants
  • K142142Quality ReportsSun Nuclear Corporation · 2014 · 2 generations on5descendants
  • K162468ClearCheckRadformation · 2016 · 3 generations on4descendants
  • K220583ClearCheck Model RADCC V2Radformation, Inc. · 2022 · 4 generations on3descendants
  • K231185MapRTVision Rt, Ltd. · 2023 · 5 generations on1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K981313SequencerImpac Medical Systems, Inc.1998—
+1K120067Mosaiq Oncology Information SystemImpac Medical Systems, Inc.20123
+2K142142Quality ReportsSun Nuclear Corporation2014—
+3K162468ClearCheckRadformation2016—
+4K220583ClearCheck Model RADCC V2Radformation, Inc.2022—
+5K231185MapRTVision Rt, Ltd.2023—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201220
201410
201610
202110
202210
202310
202510
202610
FIG. 1 — Lineage of K981313, 1998–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in IYE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new IYE device

  1. #1 K252977 Halcyon, Ethos Radiotherapy System (5.0)score 18.8 · 18 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

The FDA summary names no predicate by number.

What descends from it? (9)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K120067Mosaiq Oncology Information SystemImpac Medical Systems, Inc.20128

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Dec 13, 2018Class IIZ-0821-2019Software change controlThere is a potential that Wedge IDs were not included in the DICOM RT PLAN sent from the TPS, which will cause the field in MOSAIQ to be created with no wedge. Treatment of a field without the planned wedge will receive more dose than the…
Feb 14, 2012Not classifiedZ-1270-2012Device DesignImages used in treatment planning may belong to another patient. Risk of treatment to wrong area. Software update to upgrade Siemens installed base to the latest release of MOSAIQ version 2.00X3 SP5, for RT Therapist version 2.1A
Sep 9, 2011Not classifiedZ-0052-2012Nonconforming Material/ComponentVarian reported a problem related to certain collimator rotation values which are incorrect on TrueBeam compared to planned values in Mosaiq.
Mar 10, 2011Not classifiedZ-2662-2011Software design (manufacturing process)There's a problem in the database conversion program that is used when upgrading from the Multi-ACCS to MOSAIQ or from one version of MOSAIQ to another. If the gantry start angle is incorrect prior to pressing beam-on, the patient will be…
Sep 2, 2010Not classifiedZ-0076-2011Software designSoftware issue-- matching criteria can be configured that permits an invalid patient match, resulting in overwriting of patient records with information from a different patient.
Mar 10, 2010Not classifiedZ-1029-2011Software designComputer interface is defected. Computer based verification system for recording patient treatment on a radiotherapy treatment machine fails to record treated field.
Feb 19, 2010Not classifiedZ-0159-2011Process change controlMistreatment-- The database conversion utility used during the upgrade errantly changes the start gantry angle to zero. Any affected treatment fields, if not already treated, would start delivering from zero instead of the original…
Jul 17, 2009Not classifiedZ-1027-2011Software designPotential for improper treatment. A software error may result in potential major underdosing to targeted areas from jaw blockage of the MLC aperture (jaw intrusion), and dosing to non-targeted areas from interstitial leaf leakage (jaw…
Feb 14, 2008Not classifiedZ-1515-2008Software designSoftware issue may result in change to intended treatment field, potentially resulting in mistreatment.
Jul 7, 2006Not classifiedZ-1401-06Software designImproper treatment may be delivered if the machine configuration file is edited/set for the Varian MLC revision H file format.
Jan 6, 2005Not classifiedZ-0364-06Software designWhen using the Creatine Clearance dose calculations a software bug will allow the algorithm to assume a patients age to be in years when it is entered in months. This miscalculation may result in patients less than two years old to be…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K120067 (Impac Medical Systems, Inc., 2012) has gone furthest, with 8 descendants of its own.

How does its category compare?

All IYE devices

IYE Accelerator, Linear, Medical: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · IYE

12in 2025

2007: 232008: 142009: 202010: 232011: 112012: 282013: 182014: 202015: 202016: 212017: 232018: 212019: 192020: 202021: 192022: 122023: 182024: 92025: 122026 (partial year): 14
2007high 28 (2012) · low 9 (2024)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · IYE

170in 2025

2007: 44 days median2008: 69 days median2009: 63 days median2010: 74 days median2011: 94 days median2012: 106 days median2013: 88 days median2014: 100 days median2015: 108 days median2016: 97 days median2017: 94 days median2018: 58 days median2019: 83 days median2020: 67 days median2021: 86 days median2022: 172 days median2023: 129 days median2024: 239 days median2025: 170 days median2026 (partial year): 120 days median
2007high 239 (2024) · low 44 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · IYE

1in 2025

2007: 782008: 492009: 222010: 272011: 732012: 202013: 112014: 142015: 82016: 72017: 72018: 72019: 22020: 42021: 52022: 32023: 72024: 12025: 12026 (partial year): 4
2007high 78 (2007) · low 1 (2024)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · IYE

101in 2025

2007: 1552008: 1142009: 1742010: 2462011: 2802012: 1282013: 962014: 1242015: 1002016: 972017: 1252018: 852019: 912020: 742021: 682022: 662023: 1282024: 812025: 101
2007high 280 (2011) · low 66 (2022)2025

MAUDE reports naming product code IYE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007234478155
2008146949114
2009206322174
2010237427246
2011119473280
20122810620128
201318881196
20142010014124
2015201088100
20162197797
201723947125
20182158785
20191983291
20202067474
20211986568
202212172366
2023181297128
20249239181
2025121701101
2026141204—

What is it indicated for?

SEQUENCER is to be used to facilitate the delivery of defined radiotherapy treatment plans. SEQUENCER verifies the settings on a radiotherapy treatment machine prior to treatment and records the actual parameters after treatment. SEQUENCER can be used whenever radiotherapy treatment is prescribed.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K981313: Sequencer.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K981313

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026